FindTrial
Sign In

Screening for and preventing preeclampsia at the first trimester

Screening for and preventing preeclampsia at the first trimester

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020946
Enrollment
Unknown
Registered
2019-01-22
Start date
2019-01-31
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

High risk population:Low dose asipirin versus without asipirin

Sponsors

the Affiliated Drum Tower Hospital of Medical School of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Aged >18 years; Singleton pregnancy; Live fetus; Understand and sign the Chinese or English consent form

Exclusion criteria

Exclusion criteria: Multiple pregnancy; Major fetal defects identified at 11-13 weeks of assessment; Non-viable fetus (missed spontaneous abortion or stillbirth); Failure to sign consent, cognitive or intellectual disabilities, and inability to understand and write Chinese or English.

Design outcomes

Primary

MeasureTime frame
blood pressure;uterine artery blood flow;Placental growth factor;sFlt-1;PAPP-A;—

Countries

China

Contacts

Public ContactHu Yali

the Affiliated Drum Tower Hospital of Medical School of Nanjing University

glyyhuyali@163.com+86 13951846008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026